US Stock MarketDetailed Quotes

Theriva Biologics (TOVX)

Watchlist
  • 0.2572
  • +0.0049+1.94%
Close Apr 17 16:00 ET
  • 0.4018
  • +0.1446+56.22%
Post 19:59 ET
11.80MMarket Cap-0.12P/E (TTM)

Theriva Biologics (TOVX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
23.80%24.05M
-54.96%2.06M
-11.83%4.44M
197.10%13.13M
-18.08%4.42M
-9.35%19.43M
-26.33%4.58M
19.39%5.04M
-24.05%4.42M
4.13%5.39M
Selling and administrative expenses
108.86%15.45M
-45.04%931K
-17.94%1.89M
662.03%11.18M
-25.04%1.45M
3.88%7.4M
-16.18%1.69M
985.85%2.3M
-45.40%1.47M
-12.18%1.93M
-General and administrative expense
108.86%15.45M
-45.04%931K
-17.94%1.89M
662.03%11.18M
-25.04%1.45M
3.88%7.4M
-16.18%1.69M
985.85%2.3M
-45.40%1.47M
-12.18%1.93M
Research and development costs
-28.48%8.6M
-60.78%1.13M
-6.69%2.55M
-33.86%1.95M
-14.19%2.97M
-15.93%12.03M
-31.22%2.89M
-31.75%2.73M
-5.75%2.95M
16.19%3.46M
Operating profit
-23.80%-24.05M
54.96%-2.06M
11.83%-4.44M
-197.10%-13.13M
18.08%-4.42M
9.35%-19.43M
26.33%-4.58M
-19.39%-5.04M
24.05%-4.42M
-4.13%-5.39M
Net non-operating interest income expense
-58.82%287K
-47.83%72K
-58.86%65K
-68.79%54K
-57.89%96K
-51.56%697K
-55.77%138K
-58.64%158K
-54.59%173K
-37.36%228K
Non-operating interest income
-58.82%287K
-47.83%72K
-58.86%65K
-68.79%54K
-57.89%96K
-51.56%697K
-55.77%138K
-58.64%158K
-54.59%173K
-37.36%228K
Other net income (expense)
100.36%25K
0.00%-5K
100.49%14K
100.49%20K
-200.00%-3K
-230,866.67%-6.92M
-25.00%-5K
-47,566.67%-2.85M
-101,625.00%-4.07M
-116.67%-1K
Gain on sale of security
725.00%25K
0.00%-5K
366.67%14K
2,100.00%20K
-200.00%-3K
-233.33%-4K
-25.00%-5K
-50.00%3K
75.00%-1K
-116.67%-1K
Special income (charges)
--0
--0
--0
--0
----
---6.92M
--0
---2.85M
---4.07M
----
-Less:Impairment of capital assets
--0
--0
--0
--0
----
--5.59M
--0
--1.53M
--4.07M
----
-Write off
--0
--0
--0
----
----
--1.33M
--0
--1.33M
----
----
Income before tax
7.46%-23.74M
55.12%-2M
43.55%-4.36M
-57.02%-13.06M
16.28%-4.32M
-28.34%-25.65M
24.74%-4.45M
-101.72%-7.73M
-52.78%-8.32M
-7.43%-5.17M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
7.46%-23.74M
55.12%-2M
43.55%-4.36M
-57.02%-13.06M
16.28%-4.32M
-39.81%-25.65M
18.92%-4.45M
-133.91%-7.73M
-63.57%-8.32M
-15.34%-5.17M
Net income continuous Operations
7.46%-23.74M
55.12%-2M
43.55%-4.36M
-57.02%-13.06M
16.28%-4.32M
-39.81%-25.65M
18.92%-4.45M
-133.91%-7.73M
-63.57%-8.32M
-15.34%-5.17M
Minority interest income
Net income attributable to the parent company
7.46%-23.74M
55.12%-2M
43.55%-4.36M
-57.02%-13.06M
16.28%-4.32M
-39.81%-25.65M
18.92%-4.45M
-133.91%-7.73M
-63.57%-8.32M
-15.34%-5.17M
Preferred stock dividends
Other preferred stock dividends
1.51M
0
Net income attributable to common stockholders
1.57%-25.25M
21.16%-3.51M
43.55%-4.36M
-57.02%-13.06M
16.28%-4.32M
-39.81%-25.65M
18.92%-4.45M
-133.91%-7.73M
-63.57%-8.32M
-15.34%-5.17M
Basic earnings per share
89.07%-2.08
93.85%-0.0982
93.39%-0.45
82.00%-1.93
79.42%-1.55
33.18%-19.03
80.27%-1.5982
-40.41%-6.81
-26.12%-10.72
-0.40%-7.53
Diluted earnings per share
89.07%-2.08
93.85%-0.0982
93.39%-0.45
82.00%-1.93
79.42%-1.55
33.18%-19.03
80.27%-1.5982
-40.41%-6.81
-26.12%-10.72
-0.40%-7.53
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 23.80%24.05M-54.96%2.06M-11.83%4.44M197.10%13.13M-18.08%4.42M-9.35%19.43M-26.33%4.58M19.39%5.04M-24.05%4.42M4.13%5.39M
Selling and administrative expenses 108.86%15.45M-45.04%931K-17.94%1.89M662.03%11.18M-25.04%1.45M3.88%7.4M-16.18%1.69M985.85%2.3M-45.40%1.47M-12.18%1.93M
-General and administrative expense 108.86%15.45M-45.04%931K-17.94%1.89M662.03%11.18M-25.04%1.45M3.88%7.4M-16.18%1.69M985.85%2.3M-45.40%1.47M-12.18%1.93M
Research and development costs -28.48%8.6M-60.78%1.13M-6.69%2.55M-33.86%1.95M-14.19%2.97M-15.93%12.03M-31.22%2.89M-31.75%2.73M-5.75%2.95M16.19%3.46M
Operating profit -23.80%-24.05M54.96%-2.06M11.83%-4.44M-197.10%-13.13M18.08%-4.42M9.35%-19.43M26.33%-4.58M-19.39%-5.04M24.05%-4.42M-4.13%-5.39M
Net non-operating interest income expense -58.82%287K-47.83%72K-58.86%65K-68.79%54K-57.89%96K-51.56%697K-55.77%138K-58.64%158K-54.59%173K-37.36%228K
Non-operating interest income -58.82%287K-47.83%72K-58.86%65K-68.79%54K-57.89%96K-51.56%697K-55.77%138K-58.64%158K-54.59%173K-37.36%228K
Other net income (expense) 100.36%25K0.00%-5K100.49%14K100.49%20K-200.00%-3K-230,866.67%-6.92M-25.00%-5K-47,566.67%-2.85M-101,625.00%-4.07M-116.67%-1K
Gain on sale of security 725.00%25K0.00%-5K366.67%14K2,100.00%20K-200.00%-3K-233.33%-4K-25.00%-5K-50.00%3K75.00%-1K-116.67%-1K
Special income (charges) --0--0--0--0-------6.92M--0---2.85M---4.07M----
-Less:Impairment of capital assets --0--0--0--0------5.59M--0--1.53M--4.07M----
-Write off --0--0--0----------1.33M--0--1.33M--------
Income before tax 7.46%-23.74M55.12%-2M43.55%-4.36M-57.02%-13.06M16.28%-4.32M-28.34%-25.65M24.74%-4.45M-101.72%-7.73M-52.78%-8.32M-7.43%-5.17M
Income tax 0000000000
Net income 7.46%-23.74M55.12%-2M43.55%-4.36M-57.02%-13.06M16.28%-4.32M-39.81%-25.65M18.92%-4.45M-133.91%-7.73M-63.57%-8.32M-15.34%-5.17M
Net income continuous Operations 7.46%-23.74M55.12%-2M43.55%-4.36M-57.02%-13.06M16.28%-4.32M-39.81%-25.65M18.92%-4.45M-133.91%-7.73M-63.57%-8.32M-15.34%-5.17M
Minority interest income
Net income attributable to the parent company 7.46%-23.74M55.12%-2M43.55%-4.36M-57.02%-13.06M16.28%-4.32M-39.81%-25.65M18.92%-4.45M-133.91%-7.73M-63.57%-8.32M-15.34%-5.17M
Preferred stock dividends
Other preferred stock dividends 1.51M0
Net income attributable to common stockholders 1.57%-25.25M21.16%-3.51M43.55%-4.36M-57.02%-13.06M16.28%-4.32M-39.81%-25.65M18.92%-4.45M-133.91%-7.73M-63.57%-8.32M-15.34%-5.17M
Basic earnings per share 89.07%-2.0893.85%-0.098293.39%-0.4582.00%-1.9379.42%-1.5533.18%-19.0380.27%-1.5982-40.41%-6.81-26.12%-10.72-0.40%-7.53
Diluted earnings per share 89.07%-2.0893.85%-0.098293.39%-0.4582.00%-1.9379.42%-1.5533.18%-19.0380.27%-1.5982-40.41%-6.81-26.12%-10.72-0.40%-7.53
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More